Quick Answer
Elicio Therapeutics, Inc. reported Total Assets of $25.86 million for fiscal year 2025.
Elicio Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $25.86M | -8.2% |
| 2024 | $28.18M | +3.8% |
| 2023 | $27.15M | +19.8% |
| 2022 | $22.66M | -76.5% |
| 2021 | $96.51M | +103.8% |
| 2020 | $47.35M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $28.28M | -26.3% | -4.2% |
| June 30, 2025 | $29.53M | +87.5% | +4.9% |
| March 31, 2025 | $28.14M | +15.0% | -0.1% |
| December 31, 2024 | $28.18M | +3.8% | -26.6% |
| September 30, 2024 | $38.39M | +23.9% | +143.7% |
| June 30, 2024 | $15.75M | -58.1% | -35.7% |
| March 31, 2024 | $24.48M | -41.4% | -9.8% |
| December 31, 2023 | $27.15M | +19.8% | -12.4% |
- Elicio Therapeutics, Inc. showed a decrease of -8.2% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, Elicio Therapeutics, Inc.’s total assets has declined by 45.4% (from $47.35 million to $25.86 million).
- The most recent figure is from Elicio Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: